PETMED EXPRESS INC (PETS) Stock Fundamental Analysis
NASDAQ:PETS - Nasdaq - US7163821066 - Common Stock - Currency: USD
PETS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. PETS has a great financial health rating, but its profitability evaluates not so good. PETS has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year PETS was profitable.
In the past year PETS had a positive cash flow from operations.
Of the past 5 years PETS 4 years were profitable.
In the past 5 years PETS always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 0.25%, PETS perfoms like the industry average, outperforming 47.93% of the companies in the same industry.
Looking at the Return On Equity, with a value of 0.37%, PETS is in line with its industry, outperforming 52.89% of the companies in the same industry.
With a Return On Invested Capital value of 1.24%, PETS perfoms like the industry average, outperforming 41.32% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 0.37% | ||
| ROIC | 1.24% |
ROA(3y)2.57%
ROA(5y)8.14%
ROE(3y)2.43%
ROE(5y)9.77%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 0.14%, PETS is in line with its industry, outperforming 47.11% of the companies in the same industry.
The Operating Margin of PETS (0.62%) is worse than 61.98% of its industry peers.
With a Gross Margin value of 27.68%, PETS is not doing good in the industry: 71.07% of the companies in the same industry are doing better.
PETS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.62% | ||
| PM (TTM) | 0.14% | ||
| GM | 27.68% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.27%
GM growth 5Y-3.61%
2. Health
2.1 Basic Checks
PETS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for PETS has been increased compared to 1 year ago.
The number of shares outstanding for PETS has been increased compared to 5 years ago.
There is no outstanding debt for PETS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
PETS has an Altman-Z score of 3.45. This indicates that PETS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of PETS (3.45) is better than 80.99% of its industry peers.
PETS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.45 |
ROIC/WACC0.14
WACC9.18%
2.3 Liquidity
A Current Ratio of 1.43 indicates that PETS should not have too much problems paying its short term obligations.
PETS has a Current ratio (1.43) which is comparable to the rest of the industry.
A Quick Ratio of 1.18 indicates that PETS should not have too much problems paying its short term obligations.
PETS has a Quick ratio of 1.18. This is amongst the best in the industry. PETS outperforms 80.99% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
PETS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 102.56%, which is quite impressive.
PETS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.82%.
Measured over the past years, PETS shows a decrease in Revenue. The Revenue has been decreasing by -0.17% on average per year.
EPS 1Y (TTM)102.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
Revenue 1Y (TTM)-10.82%
Revenue growth 3Y-3.13%
Revenue growth 5Y-0.17%
Sales Q2Q%-18.88%
3.2 Future
PETS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.72% yearly.
PETS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.74% yearly.
EPS Next Y153.62%
EPS Next 2Y34.31%
EPS Next 3Y29.72%
EPS Next 5YN/A
Revenue Next Year-17.16%
Revenue Next 2Y-9.97%
Revenue Next 3Y-7.74%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
PETS is valuated quite expensively with a Price/Earnings ratio of 316.00.
Based on the Price/Earnings ratio, PETS is valued a bit more expensive than the industry average as 61.16% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 27.63, PETS is valued quite expensively.
PETS is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 316 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PETS is valued cheaper than 97.52% of the companies in the same industry.
PETS's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 76.36 | ||
| EV/EBITDA | 1.64 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PETS's earnings are expected to grow with 29.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.06
PEG (5Y)N/A
EPS Next 2Y34.31%
EPS Next 3Y29.72%
5. Dividend
5.1 Amount
No dividends for PETS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
3.16
+0.07 (+2.27%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners44.55%
Inst Owner Change0.06%
Ins Owners8.21%
Ins Owner Change13.34%
Market Cap65.29M
Analysts42.86
Price Target3.83 (21.2%)
Short Float %9.98%
Short Ratio6.33
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.59
Dividend Growth(5Y)-11.13%
DP54.34%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-96.08%
Min EPS beat(2)-488.23%
Max EPS beat(2)296.08%
EPS beat(4)2
Avg EPS beat(4)-36.55%
Min EPS beat(4)-488.23%
Max EPS beat(4)296.08%
EPS beat(8)3
Avg EPS beat(8)-169.93%
EPS beat(12)4
Avg EPS beat(12)-128.55%
EPS beat(16)4
Avg EPS beat(16)-101.84%
Revenue beat(2)0
Avg Revenue beat(2)-12.18%
Min Revenue beat(2)-12.84%
Max Revenue beat(2)-11.51%
Revenue beat(4)1
Avg Revenue beat(4)-8.81%
Min Revenue beat(4)-12.84%
Max Revenue beat(4)0.31%
Revenue beat(8)1
Avg Revenue beat(8)-6.94%
Revenue beat(12)1
Avg Revenue beat(12)-6.81%
Revenue beat(16)1
Avg Revenue beat(16)-6.96%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-80%
EPS NY rev (1m)0%
EPS NY rev (3m)20.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.9%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 316 | ||
| Fwd PE | N/A | ||
| P/S | 0.26 | ||
| P/FCF | 76.36 | ||
| P/OCF | 13.51 | ||
| P/B | 0.68 | ||
| P/tB | 1.2 | ||
| EV/EBITDA | 1.64 |
EPS(TTM)0.01
EY0.32%
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.04
FCFY1.31%
OCF(TTM)0.23
OCFY7.4%
SpS11.96
BVpS4.66
TBVpS2.64
PEG (NY)2.06
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 0.37% | ||
| ROCE | 1.57% | ||
| ROIC | 1.24% | ||
| ROICexc | 2.57% | ||
| ROICexgc | 23.86% | ||
| OM | 0.62% | ||
| PM (TTM) | 0.14% | ||
| GM | 27.68% | ||
| FCFM | 0.35% |
ROA(3y)2.57%
ROA(5y)8.14%
ROE(3y)2.43%
ROE(5y)9.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.27%
GM growth 5Y-3.61%
F-Score7
Asset Turnover1.71
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 57.96% | ||
| Cap/Sales | 1.61% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 57.63% | ||
| Profit Quality | 239.5% | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 3.45 |
F-Score7
WACC9.18%
ROIC/WACC0.14
Cap/Depr(3y)91.99%
Cap/Depr(5y)95.64%
Cap/Sales(3y)1.43%
Cap/Sales(5y)1.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
EPS Next Y153.62%
EPS Next 2Y34.31%
EPS Next 3Y29.72%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.82%
Revenue growth 3Y-3.13%
Revenue growth 5Y-0.17%
Sales Q2Q%-18.88%
Revenue Next Year-17.16%
Revenue Next 2Y-9.97%
Revenue Next 3Y-7.74%
Revenue Next 5YN/A
EBIT growth 1Y111.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year161.4%
EBIT Next 3Y51.6%
EBIT Next 5YN/A
FCF growth 1Y-96.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-81.97%
OCF growth 3Y-52.42%
OCF growth 5Y-37.46%